• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, February 6, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Using advanced imaging to study sickle cell disease

Bioengineer by Bioengineer
June 3, 2021
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Pitt’s Tamer Ibrahim uses recently optimized 7-Tesla MRI imaging technology to study SCD’s effect on the brain

IMAGE

Credit: University of Pittsburgh

Sickle Cell Disease (SCD) is a genetically inherited group of red blood cell disorders. According to the CDC, an estimated 90,000 to 100,000 people in the United States live with this disease, and it disproportionately affects Black or African Americans; it occurs in roughly 1 in every 500 individuals in this demographic.

Researchers from the University of Pittsburgh Swanson School of Engineering used a unique and powerful MRI device to study the disease’s impact on the brain and published their results in Neuroimage: Clinical. They discovered that SCD can have a severe effect on specific subfields of the hippocampus – a highly complex part of the human brain that controls learning and memory and is very susceptible to injury or disorders.

“This is a first-of-its-kind project that uses our lab’s whole-body 7-Tesla magnetic resonance imager (7T MRI) alongside our optimized Tic Tac Toe RF head coil system to get clear and quality neural images of patients affected by SCD,” said Tamer Ibrahim, professor of bioengineering and director of the Radiofrequency (RF) Research Facility and the 7-Tesla Bioengineering Research Program (7TBRP).

Individuals with SCD have red blood cells that contain an abnormal hemoglobin. This can cause the red blood cells to become hard, sticky and mutate into a unique crescent shape which inhibits the cell’s passage through small blood vessels. These blockages affect blood and oxygen flow and consequently cause tissue damage — the source of many SCD complications.

7-Tesla imaging has revealed abnormalities in the hippocampus for other neurodegenerative and neuroinflammatory diseases, so Ibrahim and his collaborators investigated SCD to see if it has a similar effect.

“Our findings support and extend previous reports of reduced hippocampal volume in SCD patients but provide more insights on the specific hippocampal subfields that are impacted,” Ibrahim explained. “The subfields are tiny structures within the hippocampus which can only be seen in ultrahigh resolution acquisitions — a feature of 7-Tesla imaging — and enhanced with the ‘Tic-Tac-Toe’ antenna technology.”

The next steps of this research are to investigate the mechanisms that lead to these structural changes in addition to electrical changes in the brain and how they relate to cognitive performance in SCD patients.

Advancing “Tic-Tac-Toe”-Themed MRI Technology

Ibrahim continues to improve the lab’s 7-Tesla imaging technology, which is leveraged in 28 active collaborative projects funded by the National Institutes of Health. It is the most widely-used RF coil system in a given 7-Tesla site.

This advanced technology can provide higher resolution and enhanced contrast human MRI images, but its operational frequency (~?297 MHz) remains an obstacle in realizing the device’s full potential. Ibrahim’s group published recent findings related to their technology in Scientific Reports.

“The major challenge of the 7-Tesla imaging is the inhomogeneities, or lack of uniformity, of the RF fields inside the human head, resulting in brain images with voids in certain anatomical regions,” said Tales Santini, a postdoctoral associate in the RF Research Facility. “In the past 12 years, our lab has developed innovative RF antenna designs which greatly increase the homogeneity of the fields, thus, enabling high resolution whole-brain images with minimal or no voids.”

###

Media Contact
Leah Russell
[email protected]

Original Source

https://www.engineering.pitt.edu/News/2021/Ibrahim-SCD/

Related Journal Article

http://dx.doi.org/10.1016/j.nicl.2021.102655

Tags: Biomedical/Environmental/Chemical EngineeringCell BiologyElectrical Engineering/ElectronicsHematologyMedicine/Healthneurobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

$1.6M gift to Markey Cancer Center will establish endowed chair in gynecologic oncology

$1.6M gift to Markey Cancer Center will establish endowed chair in gynecologic oncology

February 6, 2023
Dr. Eduard Vasilevskis

VUMC’s ‘Shed-MEDS’ protocol can reduce risk of drug interactions in older people

February 6, 2023

Scientists pinpoint protein that helps cancer-causing viruses evade immune response

February 6, 2023

Seven new species of whitefish described in Central Switzerland

February 6, 2023
Please login to join discussion

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    65 shares
    Share 26 Tweet 16
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

$1.6M gift to Markey Cancer Center will establish endowed chair in gynecologic oncology

VUMC’s ‘Shed-MEDS’ protocol can reduce risk of drug interactions in older people

Scientists pinpoint protein that helps cancer-causing viruses evade immune response

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 43 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In